Onyemaechi O Azu
Overview
Explore the profile of Onyemaechi O Azu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olojede S, Lawal S, Aladeyelu O, Olaniyi K, Moodley R, Rennie C, et al.
Life Sci
. 2022 Mar;
298:120498.
PMID: 35341824
Aim: This study investigated the impact of highly active antiretroviral therapy (HAART) loaded silver nanoparticles (AgNPs) as HAART-AgNPs on the sperm count, viability, serum hormonal profile, insulin-like growth factor I...
2.
Azu O, Olojede S, Lawal S, Oseni S, Rennie C, Offo U, et al.
J Infect Public Health
. 2021 Aug;
14(9):1237-1246.
PMID: 34455307
Introduction: A significant chunk of global life - the economy, sports, aviation, academic, and entertainment activities - has significantly been affected by the ravaging outbreak of severe acute respiratory syndrome...
3.
Offor U, Naidu E, Ogedengbe O, Aniekan P, Azu O
Toxicol Res
. 2020 Feb;
36(1):37-44.
PMID: 32042712
() is a medicinal plant, used in traditional practice for treating diseases like hypertension and diabetes mellitus. This study investigated the possible hepato-protective effect of following treatment with highly active...
4.
Olasile I, Jegede I, Ugochukwu O, Ogedengbe O, Naidu E, Peter I, et al.
Iran J Basic Med Sci
. 2019 Jan;
21(12):1322-1330.
PMID: 30627378
Objectives: Broad range of metabolic changes associated with highly active antiretroviral therapy (HAART) has been reported over decades including reproductive perturbations. The current study aimed at investigating the role of...
5.
Peter A, Naidu E, Akang E, Ogedengbe O, Offor U, Rambharose S, et al.
Toxicol Res
. 2018 Jul;
34(3):221-229.
PMID: 30057696
Tenofovir nanoparticles are novel therapeutic intervention in human immunodeficiency virus (HIV) infection reaching the virus in their sanctuary sites. However, there has been no systemic toxicity testing of this formulation...
6.
Ogedengbe O, Naidu E, Azu O
Eur J Drug Metab Pharmacokinet
. 2017 Sep;
43(2):121-135.
PMID: 28956285
The prevalence of alcohol use among HIV-infected patients undergoing antiretroviral (ARV) treatments has raised several concerns related to key therapeutic indices. These include drug interactions, compliance, efficacy and toxicity with...
7.
Ogedengbe O, Jegede A, Onanuga I, Offor U, Naidu E, Peter A, et al.
Toxicol Res
. 2016 Nov;
32(4):317-325.
PMID: 27818734
Increased access to highly active antiretroviral therapy (HAART) has made the management of drug toxicities an increasingly crucial component of HIV. This study investigated the effects of adjuvant use of...
8.
Offor U, Jegede A, Onanuga I, Naidu E, Azu O
Minerva Urol Nefrol
. 2016 Sep;
69(4):391-399.
PMID: 27583657
Background: Nephrotoxicity has become an important public health problem following the success recorded with highly active antiretroviral therapy, and there is paucity of literature reporting the attenuating influence of plant-based...
9.
Azu O
J Androl
. 2012 Jun;
33(6):1130-42.
PMID: 22700761
As antiretroviral therapy becomes increasingly accessible, the associated improvements in the health, quality of life, and survival of patients are anticipated to influence the fertility determinants of patients, specifically young...